Essential cookies are required for the website to work. With your consent, we also use performance cookies to measure traffic (Google Analytics). More about cookies

Reject
Accept all

Rigorous clinical screening

You don’t have to browse through a catalogue to find what you need.

In each therapeutic area, we select only medicines we stand for.

We were the first to

introduce biosimilar heparin

 to the Czech market.

Pharmacovigilance

Reporting side effects and the publicly available professional information service (VPOIS)

Reporting to SÚKL

Any suspected serious or unexpected side effects and other information relevant to the health of patients must be reported to the State Institute for Drug Control (SÚKL).

Legal framework

The obligation to establish a publicly available professional information service (VPOIS) arises from Act No. 378/2007 Coll., on Pharmaceuticals.

Do you need to report a side effect or request information?

Downloadable materials for your patients

Downloadable materials on diseases and information for patients under your care.

Patient materials

Do you have a question about our medicines?

Need to check availability?

Get in touch – you will speak with an expert who understands the field. Or leave us your phone number and we will call you back.

Novatin contact information
Thank you, we will be in touch as soon as possible.
Oops, something went wrong. Please try again.

Close form

Back to top